Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Tuberculosis (Edinburgh, Scotland)|July 22, 2018
An unbiased attitude is vital to exploring the Beijing genotype of Mycobacterium tuberculosisQi Zheng, Jim WerngrenJournal of Clinical Microbiology|April 12, 2003
Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rateJim Werngren, Sven E HoffnerJournal of Clinical Microbiology|April 14, 2017
Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?Jim Werngren, Erik Alm, Mikael MansjöInternational Journal of Mycobacteriology|June 1, 2017
Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015Mikael Mansjo, Jim Werngren, Sven HoffnerJournal of Clinical Microbiology|June 8, 2006
Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosisJim Werngren, Lisbeth Klintz, Sven E HoffnerTuberculosis (Edinburgh, Scotland)|June 23, 2004
Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosisPontus Juréen, Jim Werngren, Sven E HoffnerAntimicrobial Agents and Chemotherapy|July 28, 2006
Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutantsEmma Huitric, Jim Werngren, Pontus Juréen, et al.Antimicrobial Agents and Chemotherapy|March 5, 2008
Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosisPontus Juréen, Jim Werngren, Juan-Carlos Toro, et al.International Journal of Mycobacteriology|January 4, 2017
New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimensRichard M Anthony, Alice den Hertog, Mikael Mansjö, et al.The Journal of Antimicrobial Chemotherapy|March 24, 2011
Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosisAnna Engström, Nasrin Perskvist, Jim Werngren, et al.Pageof 6